Sains Malaysiana 47(10)(2018): 2473–2480

http://dx.doi.org/10.17576/jsm-2018-4710-24

 

Establishment of Stable and Secretable Tatκ-GFP Recombinant Protein: A Preliminary Report of Promoter Methylation in 293t Cell Line

(Pembangunan Protein Rekombinan Stabil dan Terembes TATκ-GFP: Laporan Awalan Proses Pemetilan Promoter pada Sel Selanjar 293T)

 

ZARIYANTEY ABD HAMID1, FAZLINA NORDIN2*, RAJA NORAZIREEN RAJA AHMAD3, BALQIS MAT RASHID1 & UBASHINI VIJAKUMARAN2

 

1Biomedical Science Programme & Centre of Health & Applied Sciences, Universiti Kebangsaan Malaysia (UKM), Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Federal Territory, Malaysia

 

2Cell Therapy Centre (CTC), Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Federal Territory, Malaysia

 

3Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan

 

Diserahkan: 6 Mac 2018/Diterima: 20 Jun 2018

 

ABSTRACT

Induced pluripotent stem cells (iPSC) is a novel technology useful for therapeutic and research applications. To date, iPSCs is produced through genetic modification that can promote mutation; making it harmful for therapeutic use. Therefore, application of non-genetic modification through direct delivery of recombinant proteins aided by protein transduction domain (PTD) enable a safer production of iPSC. This study is aimed to establish a stable production of secretable recombinant protein via recombination of green fluorescence protein (GFP) and a novel PTD peptide, namely TATκ-GFP. 293Tcell line was transfected with 20 μg/ml of TATκ-GFP plasmid and the stably transfected 293T cells were then cultured for 54 days to determine the stability of expression and secretion of TATκ-GFP recombinant protein in prolonged culture. Methylation at the CMV promoter of the TATκ-GFP plasmid was investigated following treatment of transfected cells with 3 μM/mL of demethylation agent, namely 5-Azacytidine for 72 h in three cycles. Flow cytometry analysis demonstrated a transfection efficiency of 9.33% and successful secretion of TATκ-GFP proteins into the culture medium as analysed by Western blot at 72 h post-transfection. However, the transfected cells exhibited a decreasing level of GFP expression and secretion following prolonged culture with notable stability that only sustained for two weeks. 5-Azacytidine-treated cells showed a slight increase of GFP expression compared to non-treated control, suggesting possible promoter methylation which could cause instability of TATκ-GFP expression. Conclusively, promoter methylation should be considered for future establishment of iPSCs as it could inhibit stable expression and secretion of recombinant proteins.

 

Keywords: Induced pluripotent stem cell (iPSC); methylation; protein transduction domain (PTD); trans-activator of transcription (TAT); transcription factors

 

ABSTRAK

Sel asal aruhan pluripoten (iPSC) adalah teknologi terkini yang bermanfaat bagi aplikasi perubatan dan penyelidikan. Terkini, penghasilan iPSC adalah melalui kaedah pengubahsuaian genetik yang berupaya merangsang mutasi, menjadikan ia berbahaya bagi kegunaan perubatan. Justeru, penggunaan kaedah tanpa pengubahsuaian genetik melalui penghantaran terus protein rekombinan dengan bantuan domain pentransduksi protein (PTD) membolehkan penghasilan iPSC yang lebih selamat. Kajian ini bertujuan untuk membangunkan penghasilan protein rekombinan yang stabil dan terembes melalui rekombinasi protein fluoresen hijau (GFP) dan peptida baru PTD iaitu TATκ. Sel selanjar 293T ditransfeksi dengan 20 μg/ mL plasmid TATκ-GFP dan populasi sel dengan transfeksi stabil seterusnya dikultur selama 54 hari untuk mengenal pasti kestabilan pengekspresan dan perembesan protein TATκ-GFP pada tempoh pengkulturan yang berpanjangan. Kehadiran proses pemetilan pada promoter CMV plasmid TATκ-GFP dikaji melalui rawatan ke atas sel ditransfeksi plasmid dengan 3 μM/mL agen pengenyahmetilan 5-Azasitidin selama 72 jam bagi tiga kitaran. Analisis sitometri aliran menunjukkan kecekapan transfeksi sebanyak 9.33% dan kejayaan protein TATκ-GFP dirembeskan ke dalam media pengkulturan berdasarkan analisis Western Blot selepas 72 jam transfeksi. Namun, sel ditransfeksi mempamerkan penurunan pengekspresan dan perembesan protein GFP pada tempoh pengkulturan yang berpanjangan dengan kestabilannya didapati hanya bertahan selama dua minggu. Sel terawat 5-Azasitidin menunjukkan terdapatnya sedikit peningkatan pengekspresan GFP berbanding sel kawalan tanpa rawatan yang mencadangkan kemungkinan kehadiran pemetilan pada promoter yang boleh menyebabkan ketidakstabilan pengekspresan TATκ-GFP. Kesimpulannya, pemetilan promoter perlu diberi perhatian pada masa hadapan untuk penghasilan iPSC memandangkan ia berupaya merencat kestabilan pengekspresan dan perembesan protein rekombinan.

 

Kata kunci: Faktor transkripsi; domain transduksi protein (PTD); pemetilan; sel asal aruhan pluripoten (iPSC); transkripsi pengaktif-trans(TAT)

RUJUKAN

Beerens, A.M., Al Hadithy, A.F., Rots, M.G. & Haisma, H.J. 2003. Protein transduction domains and their utility in gene therapy. Curr. Gene Ther. 3: 486-494.

Bonifaci, N., Sitia, R. & Rubartelli, A. 1995. Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS 9(9): 995-1000.

Brooks, A.R., Harkins, R.N., Wang, P., Qian, H.S., Liu, P. & Rubanyi, G.M. 2004. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. The Journal of Gene Medicine 6: 395-404.

Cheng, T., Xu, C.Y., Wang, Y.B., Chen, M., Wu, T., Zhang, J. & Xia, N.S. 2004. A rapid and efficient method to express target genes in mammalian cells by baculovirus. World Journal of Gastroenterology: WJG 10(11): 1612-1618.

Cho, H.J., Lee, C.S., Kwon, Y.W., Paek, J.S., Lee, S.H., Hur, J. & Kim, Y. 2010. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116(3): 386-395.

Deng, W. 2010. Induced pluripotent stem cells: Paths to new medicines. EMBO Reports 11(3): 161-165.

Elias, M.H., Baba, A.A., Husin, A., Sulong, S., Hassan, R., Sim, G.A., Abdul Wahid, S.F. & Ankathil, R. 2013. HOXA4 gene promoter hypermethylation as an epigenetic mechanism mediating resistance to imatinib mesylate in chronic myeloid leukemia patients. BioMed Research International 2013: 129715. doi: 10.1155/2013/129715.

Fazlina Nordin, Zariyantey Abdul Hamid, Lucas Chan, Farzin Farzaneh & Hamid, M.K.A.A. 2016. Transient expression of green fluorescent protein in integrase-defective lentiviral vector-transduced 293T cell line. In Lentiviral Vectors and Exosomes as Gene and Protein Delivery Tools, Methods in Molecular Biology, edited by Maurizio Federico. New York, NY: Springer Science + Business Media. pp. 159-173.

Fazlina Nordin, Noralisa Abdul Karim & Wahid, S.F.A. 2014. Transgene expression is transient in non-integrating lentiviral-based transduction system: An alternative approach for safety gene therapy application. Regenerative Research 3(1): 1-7.

Flinterman, M., Farzaneh, F., Habib, N., Malik, F., Gaken, J. & Tavassoli, M. 2009. Delivery of therapeutic proteins as secretable TAT fusion products. Molecular Therapy 17(2): 334- 342.

Ford, K.G., Souberbielle, B.E., Darling, D. & Farzaneh, F., 2001. Protein transduction: An alternative to genetic intervention? Gene Ther. 8: 1-4.

Grassi, G., Maccaroni, P., Meyer, R., Kaiser, H., D’Ambrosio, E., Pascale, E., Grassi, M., Kuhn, A., Di Nardo, P., Kandolf, R. & Kupper, J.H. 2003. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. Carcinogenesis 24(10): 1625-1635.

Han, W., Zhao, Y. & Fu, X. 2010. Induced pluripotent stem cells: The dragon awakens. Bioscience 60(4): 278-285.

Hedge, R.S. & Bernstein, H.D. 2006. The surprising complexity of signal sequences. Trends in Biochemical Sciences 31(10): 563-571.

Hsu, C.C., Li, H.P., Hung, Y.H., Leu, Y.W., Wu, W.H., Wang, F.S. & Huang, T.H.M. 2010. Targated methylation of CMV and E1A viral promoters. Biochemical and Biophysical Research Communications 402(2): 228-234.

Katas, H., Abdul Ghafoor, R.M. & Ee, L.C. 2014. Comparative characterization and cytotoxicity study of TAT-peptide as potential vectors for siRNA and Dicer-substrate siRNA. Drug Dev. Ind. Pharm. 40(11): 1443-1450.

Kim, D., Kim, C.H., Moon, J.I., Chung, Y.G., Chang, M.Y., Han, B.S. & Kim, K.S. 2009. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4(6): 472.

Koutsokeras, A., Purkayastha, N., Rigby, A., Subang, M.C., Sclanders, M., Vessillier, S. & Gould, D. 2014. Generation of an efficiently secreted, cell penetrating NF-κB inhibitor. The FASEB Journal 28(1): 373.

Leeper, N.J., Hunter, A.L. & Cooke, J.P. 2010. Stem cell therapy for vascular regeneration adult embryonic, and induced pluripotent stem cells. Circulation 122(5): 517-526.

Okano, H., Nakamura, M., Yoshida, K., Okana, Y., Tsuji, O., Nori, Sa. & Miura, K. 2013. Steps toward safe cell therapy using induced pluripotent stem cell. Circulation Research 112(3): 523-533.

Mariati, M., Koh, E.Y., Yeo, J.H., Ho, S.C. & Yang, Y. 2014. Toward stable gene expression in CHO cells. Bioengineered 5(5): 340-345.

Martinez, S.I., Nivet, E. & Belmonte, J.C.I. 2011. The labyrinth of nuclear reprogramming. Journal of Molecular Cell Biology 3(6): 327-329.

Michalowsky, L.A. & Jones, P.A. 1987. Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2‘-deoxycytidine resistance. Molecular and Celullar Biology 7(9): 3076-3083.

Moritz, B., Becker, P.B. & Gopfert, U. 2015. CMV promoter mutants with a reduced propensity to productivity loss in CHO cells. Scientific Reports 5: 16952. doi:10.1038/ srep16952.

Noguchi, H. & Matsumoto, S. 2006b. Protein transduction technology: A novel therapeutic perspective. Acta Med. Okayama 60: 1-11.

Nordin, F., Tye, G.J, Gaken, J. & Farzaneh, F. 2014. TATκ fusion protein of OCT-3/4 and KLF-4: Stable mixed population cell lines capable of delivering fusion proteins to target cells. Journal of Cell Science & Therapy 5(2): 158.

Nordin., F., Raja Ahmad, R.N. & Farzaneh, F. 2017. Transctivator protein: An alternative for delivery of recombinant proteins for safer reprogramming of induced pluripotent stem cell. Virus Research 235: 106-114.

Saunthararajah, Y. 2013. Key clinical observations after 5-azacytidine and decitabine treatment of myelodplastic syndromes suggest practical solutions for better outcomes. Hematology ASH Education Program 2013(1): 511-521.

Schwarze, S.R., Hruska, K.A. & Dowdy, S.F. 2000. Protein transduction: Unrestricted delivery into all cells? Trends in Cell Biology 10(7): 290-295.

Stadfeld, M. & Hochedlinger, K. 2010. Induced pluripotency: History, mechanism, and applications. Genes & Development 24(20): 2239-2263.

Takahashi, K. & Yamanaka, S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4): 663-676.

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. & Yamanaka, S. 2007. Induction of pluripotent stem cells from adult human fibroblast by defined factors. Cell 131(5): 861-872.

Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S. & Jones, J.M. 1998. Embryonic stem cell lines derived from human blastocyst. Science 282(5391): 1145-1147.

Yamanaka, S. 2009. A fresh look at iPS cells. Cell 137(1): 13-17.

Yoshida, Y. & Yamanaka, S. 2010. Recent stem cell advances: Induced pluripotent stem cells for disease modelling and stem cell-based regeneration. Circulation 122(1): 80-87.

Zhang, H., Ma, Y., Gu, J., Liao, B., Li, J. & Jin, Y. 2012. Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors. Biomaterials 33(20): 5047-5055.

Zhou, Y.Y. & Zheng, F. 2013. Integration-free methods for generating induced pluripotent stem cells. Genomics, Proteomics & Bioinformatics 11(5): 284-287.

 

*Pengarang untuk surat-menyurat; email: nordinf@ppukm.ukm.edu.my

 

 

 

 

 

 

 

 

 

sebelumnya